Succeeding in Value Communication: Introduction Blog Succeeding in Value Communication: Introduction Drawn from the experiences of the BaseCase Consulting Team, this is the introduction to ‘Succeeding…CertaraAugust 5, 2021
Application of Quantitative Systems Pharmacology to guide the optimal dosing of COVID-19 vaccines Publication Application of Quantitative Systems Pharmacology to guide the optimal dosing of COVID-19 vaccines Optimal use and distribution of coronavirus disease 2019 (COVID-19) vaccines involves adjustments of dosing. Due…CertaraJuly 31, 2021
PBPK Modeling of Tizanidine Systemic Exposure by CYP1A2 Modulation: Impact of DDIs & Smoking On-Demand Webinar PBPK Modeling of Tizanidine Systemic Exposure by CYP1A2 Modulation: Impact of DDIs & Smoking This webinar was presented on June 30, 2021 by David R. Taft, Ph.D. Professor, Pharmaceutics,…CertaraJuly 26, 2021
Why You Should Participate in the Voluntary FDA Oncology Center of Excellence Assessment Aid Program Blog Why You Should Participate in the Voluntary FDA Oncology Center of Excellence Assessment Aid Program In 2018, the FDA’s Oncology Center of Excellence developed an Assessment Aid document to help…CertaraJuly 21, 2021
What is BaseCase? Video What is BaseCase? Developing interactive and easy-to-use stakeholder engagement content market access, medical affairs, and sales field teams…CertaraJuly 20, 2021
Open-Source Modeling Tools: Fueling the Fire vs. Extinguishing the Debate On-Demand Webinar Open-Source Modeling Tools: Fueling the Fire vs. Extinguishing the Debate The paper “Opening a Debate on Open-Source Modelling Tools: Pouring Fuel on Fire vs. Extinguishing…CertaraJuly 15, 2021
Key Considerations to Ensure Maximal Probability of Antibody Drug Conjugate Development Success Blog Key Considerations to Ensure Maximal Probability of Antibody Drug Conjugate Development Success Antibody drug conjugates (ADC) are a unique way to obliterate tumor cells and represent an…CertaraJuly 8, 2021
Meet a Certara regulatory operations specialist Video Meet a Certara regulatory operations specialist Meet Rachel Bombara, Sr. Regulatory Operations Specialist at Certara. In this brief video Rachel shares…CertaraJuly 2, 2021
Maximizing Oligonucleotide Therapeutic Development: Pre-clinical and Translational Considerations Blog Maximizing Oligonucleotide Therapeutic Development: Pre-clinical and Translational Considerations This is the second of three blog posts discussing best practices for developing oligonucleotide therapeutics.…CertaraJune 25, 2021
Fundamentals of regulatory writing: the document development process Press Coverage Fundamentals of regulatory writing: the document development process Regulatory writers lead the development of high-quality regulatory documents by working incollaboration with colleagues across…CertaraJune 22, 2021